Literature DB >> 28451853

Management of Hypertension in Patients with Chronic Kidney Disease.

Seyed Mehrdad Hamrahian1.   

Abstract

Hypertension is the leading factor in the global burden of disease. It is the predominant modifiable risk factor for stroke, heart disease, and kidney failure. Chronic kidney disease (CKD) is both a common cause and sequel of uncontrolled hypertension. The pathophysiology of CKD-associated hypertension is complex and multi-factorial. This paper reviews the key pathogenic mechanisms of CKD-associated hypertension, the importance of standardized blood pressure (BP) measurement in establishing the diagnosis and management plus the significance of ambulatory BP monitoring for assessment of diurnal BP variation commonly seen in CKD. The optimal BP target in CKD remains a matter of discussion despite recent clinical trials. Medical therapy can be difficult and challenging. In addition to lifestyle modification and dietary salt restriction, treatment may need to be individualized based on co-morbidities. Combination of antihypertensive drugs, including appropriate diuretic choice and dose, is of great significance in hypertension management in CKD.

Entities:  

Keywords:  Ambulatory blood pressure monitoring; Blood pressure; Chronic kidney disease; Hypertension; Resistant hypertension

Mesh:

Year:  2017        PMID: 28451853     DOI: 10.1007/s11906-017-0739-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  82 in total

Review 1.  Loop diuretics: from the Na-K-2Cl transporter to clinical use.

Authors:  Sudha S Shankar; D Craig Brater
Journal:  Am J Physiol Renal Physiol       Date:  2003-01

2.  Parallel-group 8-week study on chlorthalidone effects in hypertensives with low kidney function.

Authors:  Massimo Cirillo; Fabiana Marcarelli; Alessandra A Mele; Massimo Romano; Cinzia Lombardi; Giancarlo Bilancio
Journal:  Hypertension       Date:  2014-01-06       Impact factor: 10.190

3.  Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients.

Authors:  P R Conlin; T J Moore; S L Swartz; E Barr; L Gazdick; C Fletcher; P DeLucca; L Demopoulos
Journal:  Hypertension       Date:  2000-09       Impact factor: 10.190

4.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

Review 5.  Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring.

Authors:  Rajiv Agarwal
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-05       Impact factor: 2.894

Review 6.  Blood pressure measurement: clinic, home, ambulatory, and beyond.

Authors:  Paul E Drawz; Mohamed Abdalla; Mahboob Rahman
Journal:  Am J Kidney Dis       Date:  2012-04-21       Impact factor: 8.860

7.  Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Paul Muntner; Amanda Anderson; Jeanne Charleston; Zhen Chen; Virginia Ford; Gail Makos; Andrew O'Connor; Kalyani Perumal; Mahboob Rahman; Susan Steigerwalt; Valerie Teal; Raymond Townsend; Matthew Weir; Jackson T Wright
Journal:  Am J Kidney Dis       Date:  2009-12-05       Impact factor: 8.860

8.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

9.  Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.

Authors:  Artemio Mojón; Diana E Ayala; Luis Piñeiro; Alfonso Otero; Juan J Crespo; Ana Moyá; Julia Bóveda; Jesús Pérez de Lis; José R Fernández; Ramón C Hermida
Journal:  Chronobiol Int       Date:  2012-10-25       Impact factor: 2.877

10.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Authors:  Bryan Williams; Thomas M MacDonald; Steve Morant; David J Webb; Peter Sever; Gordon McInnes; Ian Ford; J Kennedy Cruickshank; Mark J Caulfield; Jackie Salsbury; Isla Mackenzie; Sandosh Padmanabhan; Morris J Brown
Journal:  Lancet       Date:  2015-09-20       Impact factor: 79.321

View more
  6 in total

1.  Efficacy and safety of dual vs single renin-angiotensin-aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials.

Authors:  Mingming Zhao; Hua Qu; Rumeng Wang; Yi Yu; Meiying Chang; Sijia Ma; Hanwen Zhang; Yuejun Wang; Yu Zhang
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

2.  Twenty-four-hour systolic blood pressure variability and renal function decline in elderly male hypertensive patients with well-controlled blood pressure.

Authors:  Xi Wang; Fan Wang; Minzhi Chen; Xiaona Wang; Jin Zheng; Aimei Qin
Journal:  Clin Interv Aging       Date:  2018-04-04       Impact factor: 4.458

3.  Soluble Urokinase-Type Plasminogen Activator Receptor, Changes of 24-Hour Blood Pressure, and Progression of Chronic Kidney Disease.

Authors:  Jong Hyun Jhee; Bo Young Nam; Chan Joo Lee; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Sungha Park; Tae-Hyun Yoo
Journal:  J Am Heart Assoc       Date:  2020-12-16       Impact factor: 5.501

4.  Serum Metabolites Associated with Blood Pressure in Chronic Kidney Disease Patients.

Authors:  Fengyao Yan; Dan-Qian Chen; Jijun Tang; Ying-Yong Zhao; Yan Guo
Journal:  Metabolites       Date:  2022-03-23

5.  Relationship between the exposure to cumulative cardiovascular health behaviors and factors and chronic kidney disease-The Kailuan study.

Authors:  Jinhong Hou; Junjuan Li; Jinjie Huang; Chunhong Lu; Jing Zhou; Yang Liu; Shouling Wu; Fang Wei; Lihua Wang; Haiyan Chen; Haibo Yu; Zhe Wang; Aili Jiang
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

6.  Incidence of Acute Kidney Injury after Adrenalectomy in Patients with Primary Aldosteronism.

Authors:  Jee Young Lee; Hyoungnae Kim; Hyung Woo Kim; Geun Woo Ryu; Yooju Nam; Seonyeong Lee; Young Su Joo; Sangmi Lee; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Tae-Hyun Yoo; Hae-Ryong Yun
Journal:  Electrolyte Blood Press       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.